{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:15:02Z","timestamp":1793798102902,"version":"4.6.1"},"reference-count":316,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","award":["UCLA MIMG M. John Pickett Post-Doctoral Fellow Award"],"award-info":[{"award-number":["UCLA MIMG M. John Pickett Post-Doctoral Fellow Award"]}],"id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","award":["UCLA BSCRC Innovation Award"],"award-info":[{"award-number":["UCLA BSCRC Innovation Award"]}],"id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The microbiome has emerged as a critical, context-dependent regulator of tumorigenesis and anticancer immunity, capable of either promoting cancer progression or protecting against malignancy. This dual role is mediated by multiple interconnected mechanisms\u2014including chronic inflammation, modulation of immune responses, and alterations in host metabolic signaling. These microbiome-cancer interactions vary across organs, influencing malignancies in the colon, breast, lung, and beyond. Clinically, the microbiome significantly affects patient responses to cancer therapies, particularly immunotherapies such as immune checkpoint blockade (ICB) and chimeric antigen receptor (CAR)-T cell therapy. Although emerging therapeutic strategies aimed at modulating the microbiome have shown promising early results, challenges remain, including individual microbiome variability and the dynamic interplay between the immune system and microbial communities. Nevertheless, harnessing the microbiome holds significant potential to transform precision oncology, offering personalized cancer prevention and treatment strategies tailored to each patient\u2019s unique microbial ecosystem.<\/jats:p>","DOI":"10.1186\/s12929-025-01208-9","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:02:28Z","timestamp":1767571348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Microbiome modulation of tumorigenesis and immune responses"],"prefix":"10.1186","volume":"33","author":[{"given":"Yuning","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibai","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyue","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ruide","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"6","key":"1208_CR1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.91700","volume":"14","author":"Q Liu","year":"2024","unstructured":"Liu Q, Yang Y, Pan M, Yang F, Yu Y, Qian Z. Role of the gut microbiota in tumorigenesis and treatment. Theranostics. 2024;14(6):2304.","journal-title":"Theranostics"},{"issue":"9","key":"1208_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41568-023-00594-2","volume":"23","author":"G El Tekle","year":"2023","unstructured":"El Tekle G, Garrett WS. Bacteria in cancer initiation, promotion and progression. Nat Rev Cancer. 2023;23(9):600\u201318.","journal-title":"Nat Rev Cancer"},{"key":"1208_CR3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI184321","author":"FS Gazzaniga","year":"2025","unstructured":"Gazzaniga FS, Kasper DL. The gut microbiome and cancer response to immune checkpoint inhibitors. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI184321.","journal-title":"J Clin Invest"},{"issue":"16","key":"1208_CR4","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","volume":"73","author":"WW Tang","year":"2019","unstructured":"Tang WW, B\u00e4ckhed F, Landmesser U, Hazen SL. Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(16):2089\u2013105.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1208_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207\u201315.","journal-title":"Cell Host Microbe"},{"key":"1208_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100804","author":"Y-R Li","year":"2025","unstructured":"Li Y-R, Li Z, Zhu Y, Li M, Chen Y, Lee D, et al. Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells. Med. 2025. https:\/\/doi.org\/10.1016\/j.medj.2025.100804.","journal-title":"Med"},{"issue":"3","key":"1208_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41587-024-02226-y","volume":"43","author":"Y-R Li","year":"2025","unstructured":"Li Y-R, Zhou Y, Yu J, Kim YJ, Li M, Lee D, et al. Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method. Nat Biotechnol. 2025;43(3):329\u201344.","journal-title":"Nat Biotechnol"},{"key":"1208_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102321","author":"Y-R Li","year":"2025","unstructured":"Li Y-R, Hu J, Li Z, Zhu E, Chen Y, Halladay T, et al. Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells. Cell Rep Med. 2025. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102321.","journal-title":"Cell Rep Med"},{"issue":"1","key":"1208_CR9","doi-asserted-by":"publisher","first-page":"2374954","DOI":"10.1080\/2162402X.2024.2374954","volume":"13","author":"M Bredon","year":"2024","unstructured":"Bredon M, Danne C, Pham HP, Ruffi\u00e9 P, Bessede A, Rolhion N, et al. Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors. Oncoimmunology. 2024;13(1):2374954.","journal-title":"Oncoimmunology"},{"issue":"11","key":"1208_CR10","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","volume":"72","author":"X Kang","year":"2023","unstructured":"Kang X, Liu C, Ding Y, Ni Y, Ji F, Lau HCH, et al. Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells. Gut. 2023;72(11):2112\u201322.","journal-title":"Gut"},{"issue":"3","key":"1208_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/gutjnl-2020-323426","volume":"71","author":"W Si","year":"2022","unstructured":"Si W, Liang H, Bugno J, Xu Q, Ding X, Yang K, et al. Lactobacillus rhamnosus GG induces cGAS\/STING-dependent type I interferon and improves response to immune checkpoint blockade. Gut. 2022;71(3):521\u201333.","journal-title":"Gut"},{"issue":"12","key":"1208_CR12","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1136\/gutjnl-2023-329543","volume":"72","author":"W Fong","year":"2023","unstructured":"Fong W, Li Q, Ji F, Liang W, Lau HCH, Kang X, et al. Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1\/Kyn\/AHR axis. Gut. 2023;72(12):2272\u201385.","journal-title":"Gut"},{"key":"1208_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107952","author":"Y-R Li","year":"2023","unstructured":"Li Y-R, Ochoa CJ, Zhu Y, Kramer A, Wilson M, Fang Y, et al. Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design. iScience. 2023. https:\/\/doi.org\/10.1016\/j.isci.2023.107952.","journal-title":"iScience"},{"issue":"6","key":"1208_CR14","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/annonc\/mdx108","volume":"28","author":"N Chaput","year":"2017","unstructured":"Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann Oncol. 2017;28(6):1368\u201379.","journal-title":"Ann Oncol"},{"issue":"3","key":"1208_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41591-022-01698-2","volume":"28","author":"JA McCulloch","year":"2022","unstructured":"McCulloch JA, Davar D, Rodrigues RR, Badger JH, Fang JR, Cole AM, et al. Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. Nat Med. 2022;28(3):545\u201356.","journal-title":"Nat Med"},{"issue":"2","key":"1208_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","volume":"28","author":"L Derosa","year":"2022","unstructured":"Derosa L, Routy B, Thomas AM, Iebba V, Zalcman G, Friard S, et al. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 2022;28(2):315\u201324.","journal-title":"Nat Med"},{"issue":"10","key":"1208_CR17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1158\/2326-6066.CIR-19-1014","volume":"8","author":"Z Peng","year":"2020","unstructured":"Peng Z, Cheng S, Kou Y, Wang Z, Jin R, Hu H, et al. The gut microbiome is associated with clinical response to anti\u2013PD-1\/PD-L1 immunotherapy in gastrointestinal cancer. Cancer Immunol Res. 2020;8(10):1251\u201361.","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"1208_CR18","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy B, Lenehan JG, Miller WH Jr, Jamal R, Messaoudene M, Daisley BA, et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med. 2023;29(8):2121\u201332.","journal-title":"Nat Med"},{"issue":"18","key":"1208_CR19","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1016\/j.cell.2022.07.020","volume":"185","author":"X Zeng","year":"2022","unstructured":"Zeng X, Xing X, Gupta M, Keber FC, Lopez JG, Lee Y-CJ, et al. Gut bacterial nutrient preferences quantified in vivo. Cell. 2022;185(18):3441-56.e19.","journal-title":"Cell"},{"issue":"6","key":"1208_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41577-023-00882-w","volume":"23","author":"L Bird","year":"2023","unstructured":"Bird L. Probiotics promote local antitumour immunity. Nat Rev Immunol. 2023;23(6):343.","journal-title":"Nat Rev Immunol"},{"key":"1208_CR21","doi-asserted-by":"publisher","DOI":"10.34133\/research.0600","volume":"8","author":"Y Tang","year":"2025","unstructured":"Tang Y, Cai Q, Tian Z, Chen W, Tang H. Crosstalk between gut microbiota and cancer immunotherapy: present investigations and future perspective. Research. 2025;8:0600.","journal-title":"Research"},{"issue":"7802","key":"1208_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","volume":"580","author":"C Pleguezuelos-Manzano","year":"2020","unstructured":"Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, et al. Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli. Nature. 2020;580(7802):269\u201373.","journal-title":"Nature"},{"issue":"6","key":"1208_CR23","first-page":"1","volume":"20","author":"J Wang","year":"2020","unstructured":"Wang J, Yang H-R, Wang D-J, Wang X-X. Association between the gut microbiota and patient responses to cancer immune checkpoint inhibitors. Oncol Lett. 2020;20(6):1.","journal-title":"Oncol Lett"},{"key":"1208_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1290414","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu J, Tian R, Sun C, Guo Y, Dong L, Li Y, et al. Microbial metabolites are involved in tumorigenesis and development by regulating immune responses. Front Immunol. 2023;14:1290414.","journal-title":"Front Immunol"},{"issue":"10","key":"1208_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10102048","volume":"10","author":"GH Al-Qadami","year":"2022","unstructured":"Al-Qadami GH, Secombe KR, Subramaniam CB, Wardill HR, Bowen JM. Gut microbiota-derived short-chain fatty acids: impact on cancer treatment response and toxicities. Microorganisms. 2022;10(10):2048.","journal-title":"Microorganisms"},{"issue":"10","key":"1208_CR26","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1128\/AEM.00242-14","volume":"80","author":"C Urbaniak","year":"2014","unstructured":"Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, et al. Microbiota of human breast tissue. Appl Environ Microbiol. 2014;80(10):3007\u201314.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"1208_CR27","doi-asserted-by":"publisher","first-page":"30751","DOI":"10.1038\/srep30751","volume":"6","author":"TJ Hieken","year":"2016","unstructured":"Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep. 2016;6(1):30751.","journal-title":"Sci Rep"},{"issue":"9","key":"1208_CR28","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3390\/cancers12092465","volume":"12","author":"A Laborda-Illanes","year":"2020","unstructured":"Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-M\u00e9ndez I, et al. Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers. 2020;12(9):2465.","journal-title":"Cancers"},{"key":"1208_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101880","author":"AA Arnone","year":"2025","unstructured":"Arnone AA, Tsai Y-T, Cline JM, Wilson AS, Westwood B, Seger ME, et al. Endocrine-targeting therapies shift the breast microbiome to reduce estrogen receptor-\u03b1 breast cancer risk. Cell Rep Med. 2025. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101880.","journal-title":"Cell Rep Med"},{"key":"1208_CR30","doi-asserted-by":"crossref","unstructured":"Kumari S, Srilatha M, Nagaraju GP. Understanding the role of the microbiome in breast cancer progression. Crit Rev Oncog. 2025;30(2).","DOI":"10.1615\/CritRevOncog.2024056468"},{"issue":"3","key":"1208_CR31","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ijc.33496","volume":"149","author":"NM Teng","year":"2021","unstructured":"Teng NM, Price CA, McKee AM, Hall LJ, Robinson SD. Exploring the impact of gut microbiota and diet on breast cancer risk and progression. Int J Cancer. 2021;149(3):494\u2013504.","journal-title":"Int J Cancer"},{"issue":"1","key":"1208_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11(1):3259.","journal-title":"Nat Commun"},{"issue":"1","key":"1208_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng L-W, Ding Y, Chen Y-F, Cai Y-W, Wang L-P, et al. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2025;10(1):49.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1208_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10844-z","volume":"23","author":"G Li","year":"2023","unstructured":"Li G, Sun Y, Huang Y, Lian J, Wu S, Luo D, et al. Fusobacterium nucleatum-derived small extracellular vesicles facilitate tumor growth and metastasis via TLR4 in breast cancer. BMC Cancer. 2023;23(1):473.","journal-title":"BMC Cancer"},{"issue":"1","key":"1208_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01693-0","volume":"9","author":"Y Cao","year":"2024","unstructured":"Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, et al. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct Target Ther. 2024;9(1):15.","journal-title":"Signal Transduct Target Ther"},{"key":"1208_CR36","doi-asserted-by":"publisher","first-page":"1449912","DOI":"10.3389\/fimmu.2024.1449912","volume":"15","author":"B Ren","year":"2024","unstructured":"Ren B, Fang Y, Gu M, You L, Zhang T, Zhao Y. Microbiota-metabolism-epigenetics-immunity axis in cancer. Front Immunol. 2024;15:1449912.","journal-title":"Front Immunol"},{"issue":"1","key":"1208_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/10942912.2018.1448994","volume":"21","author":"SS Malik","year":"2018","unstructured":"Malik SS, Saeed A, Baig M, Asif N, Masood N, Yasmin A. Anticarcinogenecity of microbiota and probiotics in breast cancer. Int J Food Prop. 2018;21(1):655\u201366.","journal-title":"Int J Food Prop"},{"issue":"14","key":"1208_CR38","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.2174\/1871520621666201207085239","volume":"21","author":"R Behzadi","year":"2021","unstructured":"Behzadi R, Hormati A, Eivaziatashbeik K, Ahmadpour S, Khodadust F, Zaboli F, et al. Evaluation of anti-tumor potential of Lactobacillus acidophilus ATCC4356 culture supernatants in MCF-7 breast cancer. Anticancer Agents Med Chem. 2021;21(14):1861\u201370.","journal-title":"Anticancer Agents Med Chem"},{"issue":"2","key":"1208_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020443","volume":"15","author":"AI \u00c1lvarez-Mercado","year":"2023","unstructured":"\u00c1lvarez-Mercado AI, del Valle Cano A, Fern\u00e1ndez MF, Fontana L. Gut microbiota and breast cancer: the dual role of microbes. Cancers. 2023;15(2):443.","journal-title":"Cancers"},{"key":"1208_CR40","first-page":"1","volume":"76","author":"L Fontana","year":"2020","unstructured":"Fontana L. Microbiota and cancer therapy. Ann Nutr Metab. 2020;76:1\u2013232.","journal-title":"Ann Nutr Metab"},{"issue":"Suppl 2","key":"1208_CR41","doi-asserted-by":"publisher","first-page":"S211","DOI":"10.33549\/physiolres.934513","volume":"69","author":"R Hampl","year":"2020","unstructured":"Hampl R, St\u00e1rka L. Endocrine disruptors and gut microbiome interactions. Physiol Res. 2020;69(Suppl 2):S211.","journal-title":"Physiol Res"},{"issue":"8","key":"1208_CR42","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/ijerph15081747","volume":"15","author":"MF Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez MF, Reina-P\u00e9rez I, Astorga JM, Rodr\u00edguez-Carrillo A, Plaza-D\u00edaz J, Fontana L. Breast cancer and its relationship with the microbiota. Int J Environ Res Public Health. 2018;15(8):1747.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"1208_CR43","doi-asserted-by":"publisher","first-page":"2300688","DOI":"10.1002\/mnfr.202300688","volume":"68","author":"N Kumari","year":"2024","unstructured":"Kumari N, Kumari R, Dua A, Singh M, Kumar R, Singh P, et al. From gut to hormones: unraveling the role of gut microbiota in (phyto) estrogen modulation in health and disease. Mol Nutr Food Res. 2024;68(6):2300688.","journal-title":"Mol Nutr Food Res"},{"issue":"12","key":"1208_CR44","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1210\/jc.2014-2222","volume":"99","author":"BJ Fuhrman","year":"2014","unstructured":"Fuhrman BJ, Feigelson HS, Flores R, Gail MH, Xu X, Ravel J, et al. Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab. 2014;99(12):4632\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1208_CR45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/0008-5472.CAN-16-1717","volume":"77","author":"JN Sampson","year":"2017","unstructured":"Sampson JN, Falk RT, Schairer C, Moore SC, Fuhrman BJ, Dallal CM, et al. Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women. Cancer Res. 2017;77(4):918\u201325.","journal-title":"Cancer Res"},{"issue":"6","key":"1208_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039745","volume":"7","author":"R Flores","year":"2012","unstructured":"Flores R, Shi J, Gail MH, Gajer P, Ravel J, Goedert JJ. Association of fecal microbial diversity and taxonomy with selected enzymatic functions. PLoS ONE. 2012;7(6):e39745.","journal-title":"PLoS ONE"},{"issue":"1","key":"1208_CR47","doi-asserted-by":"publisher","first-page":"28061","DOI":"10.1038\/srep28061","volume":"6","author":"AA Chan","year":"2016","unstructured":"Chan AA, Bashir M, Rivas MN, Duvall K, Sieling PA, Pieber TR, et al. Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors. Sci Rep. 2016;6(1):28061.","journal-title":"Sci Rep"},{"issue":"49","key":"1208_CR48","doi-asserted-by":"publisher","first-page":"18586","DOI":"10.1074\/jbc.RA119.010950","volume":"294","author":"SM Ervin","year":"2019","unstructured":"Ervin SM, Li H, Lim L, Roberts LR, Liang X, Mani S, et al. Gut microbial \u03b2-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem. 2019;294(49):18586\u201399.","journal-title":"J Biol Chem"},{"issue":"2","key":"1208_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ijc.23060","volume":"122","author":"R Suzuki","year":"2008","unstructured":"Suzuki R, Rylander-Rudqvist T, Ye W, Saji S, Adlercreutz H, Wolk A. Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status\u2014a prospective cohort study among Swedish women. Int J Cancer. 2008;122(2):403\u201312.","journal-title":"Int J Cancer"},{"issue":"7","key":"1208_CR50","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/01635581.2020.1784444","volume":"73","author":"AG Zengul","year":"2021","unstructured":"Zengul AG, Demark-Wahnefried W, Barnes S, Morrow CD, Bertrand B, Berryhill TF, et al. Associations between dietary fiber, the fecal microbiota and estrogen metabolism in postmenopausal women with breast cancer. Nutr Cancer. 2021;73(7):1108\u201317.","journal-title":"Nutr Cancer"},{"issue":"3","key":"1208_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/biology14030251","volume":"14","author":"I Zalila-Kolsi","year":"2025","unstructured":"Zalila-Kolsi I, Dhieb D, Osman HA, Mekideche H. The gut microbiota and colorectal cancer: understanding the link and exploring therapeutic interventions. Biology. 2025;14(3):251.","journal-title":"Biology"},{"issue":"6","key":"1208_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061913","volume":"15","author":"S Singh","year":"2023","unstructured":"Singh S, Sharma P, Sarma DK, Kumawat M, Tiwari R, Verma V, et al. Implication of obesity and gut microbiome dysbiosis in the etiology of colorectal cancer. Cancers. 2023;15(6):1913.","journal-title":"Cancers"},{"issue":"4","key":"1208_CR53","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847638","volume":"20","author":"MR Rubinstein","year":"2019","unstructured":"Rubinstein MR, Baik JE, Lagana SM, Han RP, Raab WJ, Sahoo D, et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt\/\u03b2\u2010catenin modulator Annexin A1. EMBO Rep. 2019;20(4):e47638.","journal-title":"EMBO Rep"},{"issue":"6","key":"1208_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061406","volume":"12","author":"L S\u00e1nchez-Alcoholado","year":"2020","unstructured":"S\u00e1nchez-Alcoholado L, Ramos-Molina B, Otero A, Laborda-Illanes A, Ord\u00f3\u00f1ez R, Medina JA, et al. The role of the gut microbiome in colorectal cancer development and therapy response. Cancers. 2020;12(6):1406.","journal-title":"Cancers"},{"issue":"7","key":"1208_CR55","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152891","volume":"22","author":"Q Meng","year":"2021","unstructured":"Meng Q, Gao Q, Mehrazarin S, Tangwanichgapong K, Wang Y, Huang Y, et al. Fusobacterium nucleatum secretes amyloid\u2010like FadA to enhance pathogenicity. EMBO Rep. 2021;22(7):e52891.","journal-title":"EMBO Rep"},{"issue":"10","key":"1208_CR56","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.annonc.2020.06.003","volume":"31","author":"G Serna","year":"2020","unstructured":"Serna G, Ruiz-Pace F, Hernando J, Alonso L, Fasani R, Landolfi S, et al. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann Oncol. 2020;31(10):1366\u201375.","journal-title":"Ann Oncol"},{"issue":"2","key":"1208_CR57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195\u2013206.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"1208_CR58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.chom.2016.07.006","volume":"20","author":"J Abed","year":"2016","unstructured":"Abed J, Emg\u00e5rd JE, Zamir G, Faroja M, Almogy G, Grenov A, et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe. 2016;20(2):215\u201325.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"1208_CR59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344\u201355.","journal-title":"Immunity"},{"key":"1208_CR60","doi-asserted-by":"crossref","unstructured":"Sch\u00f6pf F, Marongiu GL, Milaj K, Sprink T, Kikhney J, Moter A, et al. Structural basis of Fusobacterium nucleatum adhesin Fap2 interaction with receptors on cancer and immune cells. bioRxiv. 2024:2024.02. 28.582045.","DOI":"10.1101\/2024.02.28.582045"},{"issue":"37","key":"1208_CR61","doi-asserted-by":"publisher","first-page":"15354","DOI":"10.1073\/pnas.1010203108","volume":"108","author":"AC Goodwin","year":"2011","unstructured":"Goodwin AC, Shields CED, Wu S, Huso DL, Wu X, Murray-Stewart TR, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci USA. 2011;108(37):15354\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1208_CR62","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2185028","volume":"15","author":"MW Dougherty","year":"2023","unstructured":"Dougherty MW, Jobin C. Intestinal bacteria and colorectal cancer: etiology and treatment. Gut Microbes. 2023;15(1):2185028.","journal-title":"Gut Microbes"},{"issue":"2","key":"1208_CR63","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ismej.2011.109","volume":"6","author":"T Wang","year":"2012","unstructured":"Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6(2):320\u20139.","journal-title":"ISME J"},{"issue":"4","key":"1208_CR64","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","volume":"25","author":"J Wirbel","year":"2019","unstructured":"Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679\u201389.","journal-title":"Nat Med"},{"issue":"1","key":"1208_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-024-00865-1","volume":"11","author":"ME Krueger","year":"2025","unstructured":"Krueger ME, Boles JS, Simon ZD, Alvarez SD, McFarland NR, Okun MS, et al. Comparative analysis of Parkinson\u2019s and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion. npj Parkinson\u2019s Dis. 2025;11(1):1\u201318.","journal-title":"npj Parkinson's Dis."},{"issue":"1","key":"1208_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01344-1","volume":"16","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhang Q, Zhang H, Yi Z, Ma H, Wang X, et al. Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism. Genome Med. 2024;16(1):77.","journal-title":"Genome Med"},{"issue":"2","key":"1208_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/14737140.2025.2452338","volume":"25","author":"K Kie\u0142bowski","year":"2025","unstructured":"Kie\u0142bowski K, Szwedkowicz A, Plewa P, Bakinowska E, Becht R, Pawlik A. Anticancer properties of histone deacetylase inhibitors\u2013what is their potential? Expert Rev Anticancer Ther. 2025;25(2):105\u201320.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"1208_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23318","volume":"34","author":"Q Gui","year":"2020","unstructured":"Gui Q, Li H, Wang A, Zhao X, Tan Z, Chen L, et al. The association between gut butyrate\u2010producing bacteria and non\u2010small\u2010cell lung cancer. J Clin Lab Anal. 2020;34(8):e23318.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"1208_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/nu9010025","volume":"9","author":"H Zeng","year":"2017","unstructured":"Zeng H, Taussig DP, Cheng W-H, Johnson LK, Hakkak R. Butyrate inhibits cancerous HCT116 colon cell proliferation but to a lesser extent in noncancerous NCM460 colon cells. Nutrients. 2017;9(1):25.","journal-title":"Nutrients"},{"key":"1208_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102645","volume":"121","author":"B Golijanin","year":"2023","unstructured":"Golijanin B, Malshy K, Khaleel S, Lagos G, Amin A, Cheng L, et al. Evolution of the HIF targeted therapy in clear cell renal cell carcinoma. Cancer Treat Rev. 2023;121:102645.","journal-title":"Cancer Treat Rev"},{"key":"1208_CR71","doi-asserted-by":"publisher","first-page":"1133782","DOI":"10.3389\/fmicb.2023.1133782","volume":"14","author":"B-Y Yang","year":"2023","unstructured":"Yang B-Y, Zhao F-Z, Li X-H, Zhao M-S, Lv J-C, Shi M-J, et al. Alteration of pro-carcinogenic gut microbiota is associated with clear cell renal cell carcinoma tumorigenesis. Front Microbiol. 2023;14:1133782.","journal-title":"Front Microbiol"},{"key":"1208_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.913718","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Ma J, Dong Y, Yang Z, Zhao N, Liu Q, et al. Characteristics of gut microbiota in patients with clear cell renal cell carcinoma. Front Microbiol. 2022;13:913718.","journal-title":"Front Microbiol"},{"key":"1208_CR73","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.biopha.2017.06.066","volume":"93","author":"F Mahmoodpoor","year":"2017","unstructured":"Mahmoodpoor F, Saadat YR, Barzegari A, Ardalan M, Vahed SZ. The impact of gut microbiota on kidney function and pathogenesis. Biomed Pharmacother. 2017;93:412\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"1208_CR74","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1200\/JCO.2004.06.121","volume":"22","author":"S Negrier","year":"2004","unstructured":"Negrier S, Perol D, Menetrier-Caux C, Escudier B, Pallardy M, Ravaud A, et al. Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6\u2014from the Groupe Francais d\u2019Immunotherapie. J Clin Oncol. 2004;22(12):2371\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1208_CR75","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/cam4.7","volume":"1","author":"BL Petrella","year":"2012","unstructured":"Petrella BL, Vincenti MP. Interleukin-1\u03b2 mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein \u03b2. Cancer Med. 2012;1(1):17\u201327.","journal-title":"Cancer Med"},{"key":"1208_CR76","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cellsig.2017.01.017","volume":"32","author":"Z Quan","year":"2017","unstructured":"Quan Z, He Y, Luo C, Xia Y, Zhao Y, Liu N, et al. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b. Cell Signal. 2017;32:48\u201358.","journal-title":"Cell Signal"},{"issue":"5","key":"1208_CR77","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1158\/0008-5472.CAN-13-1671","volume":"74","author":"T Cuadros","year":"2014","unstructured":"Cuadros T, Trilla E, Sarro E, Vila MR, Vilardell J, de Torres I, et al. HAVCR\/KIM-1 activates the IL-6\/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome. Cancer Res. 2014;74(5):1416\u201328.","journal-title":"Cancer Res"},{"issue":"3","key":"1208_CR78","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/path.5267","volume":"248","author":"C Corr\u00f2","year":"2019","unstructured":"Corr\u00f2 C, Healy ME, Engler S, Bodenmiller B, Li Z, Schraml P, et al. IL\u20108 and CXCR1 expression is associated with cancer stem cell\u2010like properties of clear cell renal cancer. J Pathol. 2019;248(3):377\u201389.","journal-title":"J Pathol"},{"key":"1208_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02663","volume":"9","author":"M Peng","year":"2018","unstructured":"Peng M, Tabashsum Z, Patel P, Bernhardt C, Biswas D. Linoleic acids overproducing Lactobacillus casei limits growth, survival, and virulence of Salmonella Typhimurium and enterohaemorrhagic Escherichia coli. Front Microbiol. 2018;9:2663.","journal-title":"Front Microbiol"},{"key":"1208_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/or.2024.1393664","volume":"18","author":"O Kovaleva","year":"2024","unstructured":"Kovaleva O, Podlesnaya P, Gratchev A. Resident microbiome of kidney tumors. Oncol Rev. 2024;18:1393664.","journal-title":"Oncol Rev"},{"issue":"3","key":"1208_CR81","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.euo.2019.09.001","volume":"3","author":"A-KA Lalani","year":"2020","unstructured":"Lalani A-KA, Xie W, Braun DA, Kaymakcalan M, Boss\u00e9 D, Steinharter JA, et al. Effect of antibiotic use on outcomes with systemic therapies in metastatic renal cell carcinoma. Eur Urol Oncol. 2020;3(3):372\u201381.","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"1208_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188559","volume":"1876","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty S, Balan M, Sabarwal A, Choueiri TK, Pal S. Metabolic reprogramming in renal cancer: events of a metabolic disease. Biochimica et Biophysica Acta (BBA)-Rev Cancer. 2021;1876(1):188559.","journal-title":"Biochimica et Biophysica Acta (BBA)-Rev Cancer"},{"key":"1208_CR83","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","volume":"32","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel P, Poesen R, Meijers B. The gut\u2013kidney axis. Pediatr Nephrol. 2017;32:2005\u201314.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"1208_CR84","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000512326","volume":"88","author":"AM Barbosa","year":"2021","unstructured":"Barbosa AM, Gomes-Gon\u00e7alves A, Castro AG, Torrado E. Immune system efficiency in cancer and the microbiota influence. Pathobiology. 2021;88(2):170\u201386.","journal-title":"Pathobiology"},{"issue":"2","key":"1208_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/cells14020084","volume":"14","author":"E Monti","year":"2025","unstructured":"Monti E, Vianello C, Leoni I, Galvani G, Lippolis A, D\u2019Amico F, et al. Gut microbiome modulation in hepatocellular carcinoma: preventive role in NAFLD\/NASH progression and potential applications in immunotherapy-based strategies. Cells. 2025;14(2):84.","journal-title":"Cells"},{"issue":"6391","key":"1208_CR86","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5931","volume":"360","author":"C Ma","year":"2018","unstructured":"Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome\u2013mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360(6391):eaan5931.","journal-title":"Science"},{"issue":"11","key":"1208_CR87","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg H, Adolph TE, Trauner M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab. 2022;34(11):1700\u201318.","journal-title":"Cell Metab"},{"issue":"11","key":"1208_CR88","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut\u2013liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21(11):719\u201333.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"1208_CR89","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jhep.2012.06.011","volume":"57","author":"H-L Zhang","year":"2012","unstructured":"Zhang H-L, Yu L-X, Yang W, Tang L, Lin Y, Wu H, et al. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J Hepatol. 2012;57(4):803\u201312.","journal-title":"J Hepatol"},{"key":"1208_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01890-9","author":"X Wang","year":"2025","unstructured":"Wang X, Fang Y, Liang W, Cai Y, Wong CC, Wang J, et al. Gut\u2013liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice. Nat Microbiol. 2025. https:\/\/doi.org\/10.1038\/s41564-024-01890-9.","journal-title":"Nat Microbiol"},{"issue":"10","key":"1208_CR91","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s43018-021-00251-3","volume":"2","author":"N Iida","year":"2021","unstructured":"Iida N, Mizukoshi E, Yamashita T, Yutani M, Seishima J, Wang Z, et al. Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis. Nat Cancer. 2021;2(10):1039\u201354.","journal-title":"Nat Cancer"},{"issue":"4","key":"1208_CR92","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/ijo.2024.5632","volume":"64","author":"J Sun","year":"2024","unstructured":"Sun J, Chen S, Zang D, Sun H, Sun Y, Chen J. Butyrate as a promising therapeutic target in cancer: from pathogenesis to clinic. Int J Oncol. 2024;64(4):44.","journal-title":"Int J Oncol"},{"issue":"5","key":"1208_CR93","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/HEP.0000000000000406","volume":"80","author":"N Daniel","year":"2024","unstructured":"Daniel N, Genua F, Jenab M, May\u00e9n A-L, Chatziioannou AC, Keski-Rahkonen P, et al. The role of the gut microbiome in the development of hepatobiliary cancers. Hepatology. 2024;80(5):1252\u201369.","journal-title":"Hepatology"},{"issue":"6","key":"1208_CR94","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cell.2005.11.032","volume":"123","author":"F M\u00e9graud","year":"2005","unstructured":"M\u00e9graud F. A humble bacterium sweeps this year\u2019s Nobel Prize. Cell. 2005;123(6):975\u20136.","journal-title":"Cell"},{"issue":"9","key":"1208_CR95","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm.2015","volume":"15","author":"S Wu","year":"2009","unstructured":"Wu S, Rhee K-J, Albesiano E, Rabizadeh S, Wu X, Yen H-R, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15(9):1016\u201322.","journal-title":"Nat Med"},{"issue":"2","key":"1208_CR96","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1101\/gr.126516.111","volume":"22","author":"M Castellarin","year":"2012","unstructured":"Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299\u2013306.","journal-title":"Genome Res"},{"issue":"2","key":"1208_CR97","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1101\/gr.126573.111","volume":"22","author":"AD Kostic","year":"2012","unstructured":"Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292\u20138.","journal-title":"Genome Res"},{"issue":"8013","key":"1208_CR98","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41586-024-07372-6","volume":"629","author":"Y Miyamoto","year":"2024","unstructured":"Miyamoto Y, Kikuta J, Matsui T, Hasegawa T, Fujii K, Okuzaki D, et al. Periportal macrophages protect against commensal-driven liver inflammation. Nature. 2024;629(8013):901\u20139.","journal-title":"Nature"},{"key":"1208_CR99","doi-asserted-by":"crossref","unstructured":"Lau HC-H, Zhang X, Ji F, Lin Y, Liang W, Li Q, et al. Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid. EBioMedicine. 2024;100.","DOI":"10.1016\/j.ebiom.2023.104952"},{"issue":"1","key":"1208_CR100","doi-asserted-by":"publisher","first-page":"G32","DOI":"10.1152\/ajpgi.00024.2012","volume":"303","author":"Y Wang","year":"2012","unstructured":"Wang Y, Liu Y, Sidhu A, Ma Z, McClain C, Feng W. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am J Physiol Gastrointest Liver Physiol. 2012;303(1):G32\u201341.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1208_CR101","doi-asserted-by":"publisher","first-page":"1047570","DOI":"10.3389\/fimmu.2022.1047570","volume":"13","author":"T Li","year":"2022","unstructured":"Li T, Lin X, Shen B, Zhang W, Liu Y, Liu H, et al. Akkermansia muciniphila suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6+ natural killer T cells. Front Immunol. 2022;13:1047570.","journal-title":"Front Immunol"},{"issue":"6","key":"1208_CR102","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.ejca.2011.06.010","volume":"48","author":"A Sharma","year":"2012","unstructured":"Sharma A, Rath G, Chaudhary S, Thakar A, Mohanti BK, Bahadur S. Lactobacillus brevis CD2 lozenges reduce radiation-and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer. 2012;48(6):875\u201381.","journal-title":"Eur J Cancer"},{"key":"1208_CR103","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00692-13","author":"JP Zackular","year":"2013","unstructured":"Zackular JP, Baxter NT, Iverson KD, Sadler WD, Petrosino JF, Chen GY, et al. The gut microbiome modulates colon tumorigenesis. MBio. 2013. https:\/\/doi.org\/10.1128\/mbio.00692-13.","journal-title":"MBio"},{"issue":"2","key":"1208_CR104","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.trecan.2019.12.007","volume":"6","author":"AG Ram\u00edrez-Labrada","year":"2020","unstructured":"Ram\u00edrez-Labrada AG, Isla D, Artal A, Arias M, Rezusta A, Pardo J, et al. The influence of lung microbiota on lung carcinogenesis, immunity, and immunotherapy. Trends Cancer. 2020;6(2):86\u201397.","journal-title":"Trends Cancer"},{"issue":"8","key":"1208_CR105","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00432-021-03644-0","volume":"147","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Liu Y, Li S, Peng Z, Liu X, Chen J, et al. Role of lung and gut microbiota on lung cancer pathogenesis. J Cancer Res Clin Oncol. 2021;147(8):2177\u201386.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"1208_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01722-y","volume":"9","author":"R Li","year":"2024","unstructured":"Li R, Li J, Zhou X. Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduct Target Ther. 2024;9(1):19.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1208_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-00138-z","volume":"4","author":"N-N Liu","year":"2020","unstructured":"Liu N-N, Ma Q, Ge Y, Yi C-X, Wei L-Q, Tan J-C, et al. Microbiome dysbiosis in lung cancer: from composition to therapy. NPJ Precis Oncol. 2020;4(1):33.","journal-title":"NPJ Precis Oncol"},{"issue":"4","key":"1208_CR108","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.21037\/tlcr-20-156","volume":"9","author":"N Xu","year":"2020","unstructured":"Xu N, Wang L, Li C, Ding C, Li C, Fan W, et al. Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms. Transl Lung Cancer Res. 2020;9(4):1554.","journal-title":"Transl Lung Cancer Res"},{"issue":"9","key":"1208_CR109","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1164\/rccm.201710-2118OC","volume":"198","author":"J-CJ Tsay","year":"2018","unstructured":"Tsay J-CJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, et al. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am J Respir Crit Care Med. 2018;198(9):1188\u201398.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1208_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.31","volume":"1","author":"LN Segal","year":"2016","unstructured":"Segal LN, Clemente JC, Tsay J-CJ, Koralov SB, Keller BC, Wu BG, et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol. 2016;1(5):1\u201311.","journal-title":"Nat Microbiol"},{"issue":"6","key":"1208_CR111","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.3892\/ol.2017.6048","volume":"13","author":"G-S Shang","year":"2017","unstructured":"Shang G-S, Liu L, Qin Y-W. IL-6 and TNF-\u03b1 promote metastasis of lung cancer by inducing epithelial-mesenchymal transition. Oncol Lett. 2017;13(6):4657\u201360.","journal-title":"Oncol Lett"},{"issue":"19","key":"1208_CR112","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.3390\/cancers14194813","volume":"14","author":"M Bou Zerdan","year":"2022","unstructured":"Bou Zerdan M, Kassab J, Meouchy P, Haroun E, Nehme R, Bou Zerdan M, et al. The lung microbiota and lung cancer: a growing relationship. Cancers. 2022;14(19):4813.","journal-title":"Cancers"},{"issue":"6350","key":"1208_CR113","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1126\/science.aam5336","volume":"357","author":"AL Steed","year":"2017","unstructured":"Steed AL, Christophi GP, Kaiko GE, Sun L, Goodwin VM, Jain U, et al. The microbial metabolite desaminotyrosine protects from influenza through type I interferon. Science. 2017;357(6350):498\u2013502.","journal-title":"Science"},{"issue":"7","key":"1208_CR114","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.7150\/jca.28077","volume":"10","author":"W Zhang","year":"2019","unstructured":"Zhang W, Luo J, Dong X, Zhao S, Hao Y, Peng C, et al. Salivary microbial dysbiosis is associated with systemic inflammatory markers and predicted oral metabolites in non-small cell lung cancer patients. J Cancer. 2019;10(7):1651.","journal-title":"J Cancer"},{"issue":"3","key":"1208_CR115","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/thoraxjnl-2020-215542","volume":"76","author":"HD Hosgood","year":"2021","unstructured":"Hosgood HD, Cai Q, Hua X, Long J, Shi J, Wan Y, et al. Variation in oral microbiome is associated with future risk of lung cancer among never-smokers. Thorax. 2021;76(3):256\u201363.","journal-title":"Thorax"},{"key":"1208_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2049-2618-1-19","volume":"1","author":"LN Segal","year":"2013","unstructured":"Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Chen H, et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome. 2013;1:1\u201312.","journal-title":"Microbiome"},{"issue":"1","key":"1208_CR117","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13027-024-00590-7","volume":"19","author":"K Javadi","year":"2024","unstructured":"Javadi K, Ferdosi-Shahandashti E, Rajabnia M, Khaledi M. Vaginal microbiota and gynecological cancers: a complex and evolving relationship. Infect Agent Cancer. 2024;19(1):27.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"1208_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00577-7","volume":"10","author":"J Wu","year":"2024","unstructured":"Wu J, Li J, Yan M, Xiang Z. Gut and oral microbiota in gynecological cancers: interaction, mechanism, and therapeutic value. NPJ Biofilms Microbiomes. 2024;10(1):104.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"3","key":"1208_CR119","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/pharmaceutics15030948","volume":"15","author":"X Zhao","year":"2023","unstructured":"Zhao X, Liu Z, Chen T. Potential role of vaginal microbiota in ovarian cancer carcinogenesis, progression and treatment. Pharmaceutics. 2023;15(3):948.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1208_CR120","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41598-023-27555-x","volume":"13","author":"AE Asangba","year":"2023","unstructured":"Asangba AE, Chen J, Goergen KM, Larson MC, Oberg AL, Casarin J, et al. Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response. Sci Rep. 2023;13(1):730.","journal-title":"Sci Rep"},{"issue":"3","key":"1208_CR121","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/medicina60030516","volume":"60","author":"S-Y Choi","year":"2024","unstructured":"Choi S-Y, Choi J-H. Ovarian cancer and the microbiome: connecting the dots for early diagnosis and therapeutic innovations\u2014a review. Medicina. 2024;60(3):516.","journal-title":"Medicina"},{"key":"1208_CR122","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00460-13","author":"SS Witkin","year":"2013","unstructured":"Witkin SS, Mendes-Soares H, Linhares IM, Jayaram A, Ledger WJ, Forney LJ. Influence of vaginal bacteria and D-and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. MBio. 2013. https:\/\/doi.org\/10.1128\/mbio.00460-13.","journal-title":"MBio"},{"issue":"9-10","key":"1208_CR123","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.resmic.2017.04.001","volume":"168","author":"G Tachedjian","year":"2017","unstructured":"Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017;168(9\u201310):782\u201392.","journal-title":"Res Microbiol"},{"issue":"7","key":"1208_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28898","volume":"95","author":"C Li","year":"2023","unstructured":"Li C, Feng Y, Yang C, Wang D, Zhang D, Luo X, et al. Association between vaginal microbiota and the progression of ovarian cancer. J Med Virol. 2023;95(7):e28898.","journal-title":"J Med Virol"},{"issue":"1","key":"1208_CR125","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41698-020-0126-x","volume":"4","author":"P \u0141aniewski","year":"2020","unstructured":"\u0141aniewski P, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment. NPJ Precis Oncol. 2020;4(1):22.","journal-title":"NPJ Precis Oncol"},{"key":"1208_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-021-00295-2","volume":"27","author":"A Sipos","year":"2021","unstructured":"Sipos A, Ujlaki G, Mik\u00f3 E, Maka E, Szab\u00f3 J, Uray K, et al. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Mol Med. 2021;27:1\u201320.","journal-title":"Mol Med"},{"issue":"3","key":"1208_CR127","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s12602-019-09596-9","volume":"12","author":"Y Rahbar Saadat","year":"2020","unstructured":"Rahbar Saadat Y, Pourseif MM, Zununi Vahed S, Barzegari A, Omidi Y, Barar J. Modulatory role of vaginal-isolated lactococcus lactis on the expression of miR-21, miR-200b, and TLR-4 in CAOV-4 cells and in silico revalidation. Probiotics Antimicrob Proteins. 2020;12(3):1083\u201396.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"2","key":"1208_CR128","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372\u201385.","journal-title":"Immunity"},{"key":"1208_CR129","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cotox.2017.02.001","volume":"2","author":"L Zhang","year":"2017","unstructured":"Zhang L, Nichols RG, Patterson AD. The aryl hydrocarbon receptor as a moderator of host-microbiota communication. Curr Opin Toxicol. 2017;2:30\u20135.","journal-title":"Curr Opin Toxicol"},{"key":"1208_CR130","doi-asserted-by":"crossref","unstructured":"Coggshall K, Brooks L, Nagarajan P, Arron ST. The microbiome and its contribution to skin cancer. Microbiome and Cancer. 2019, p. 87\u2013106.","DOI":"10.1007\/978-3-030-04155-7_5"},{"issue":"3","key":"1208_CR131","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/ijms23031813","volume":"23","author":"YR Woo","year":"2022","unstructured":"Woo YR, Cho SH, Lee JD, Kim HS. The human microbiota and skin cancer. Int J Mol Sci. 2022;23(3):1813.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1208_CR132","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1111\/1346-8138.15633","volume":"48","author":"S Mizuhashi","year":"2021","unstructured":"Mizuhashi S, Kajihara I, Sawamura S, Kanemaru H, Makino K, Aoi J, et al. Skin microbiome in acral melanoma: Corynebacterium is associated with advanced melanoma. J Dermatol. 2021;48(1):e15\u20136.","journal-title":"J Dermatol"},{"issue":"7","key":"1208_CR133","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1084\/jem.20090207","volume":"206","author":"L Wang","year":"2009","unstructured":"Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6\u2013Stat3 signaling pathway. J Exp Med. 2009;206(7):1457\u201364.","journal-title":"J Exp Med"},{"issue":"3","key":"1208_CR134","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1084\/jem.20171079","volume":"215","author":"VK Ridaura","year":"2018","unstructured":"Ridaura VK, Bouladoux N, Claesen J, Chen YE, Byrd AL, Constantinides MG, et al. Contextual control of skin immunity and inflammation by Corynebacterium. J Exp Med. 2018;215(3):785\u201399.","journal-title":"J Exp Med"},{"issue":"12","key":"1208_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029020","volume":"6","author":"K Tsuda","year":"2011","unstructured":"Tsuda K, Yamanaka K, Linan W, Miyahara Y, Akeda T, Nakanishi T, et al. Intratumoral injection of Propionibacterium acnes suppresses malignant melanoma by enhancing Th1 immune responses. PLoS ONE. 2011;6(12):e29020.","journal-title":"PLoS ONE"},{"issue":"6","key":"1208_CR136","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/phpp.12411","volume":"34","author":"Z Wang","year":"2018","unstructured":"Wang Z, Choi JE, Wu CC, Di Nardo A. Skin commensal bacteria Staphylococcus epidermidis promote survival of melanocytes bearing UVB\u2010induced DNA damage, while bacteria Propionibacterium acnes inhibit survival of melanocytes by increasing apoptosis. Photodermatol Photoimmunol Photomed. 2018;34(6):405\u201314.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"2","key":"1208_CR137","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao4502","volume":"4","author":"T Nakatsuji","year":"2018","unstructured":"Nakatsuji T, Chen TH, Butcher AM, Trzoss LL, Nam S-J, Shirakawa KT, et al. A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Sci Adv. 2018;4(2):eaao4502.","journal-title":"Sci Adv"},{"issue":"5192","key":"1208_CR138","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y Chang","year":"1994","unstructured":"Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-sssociated kaposi\u2019s sarcoma. Science. 1994;266(5192):1865\u20139.","journal-title":"Science"},{"issue":"1","key":"1208_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.77","volume":"3","author":"JC Becker","year":"2017","unstructured":"Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebb\u00e9 C, Veness M, et al. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3(1):1\u201317.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"1208_CR140","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"1208_CR141","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1365-2958.1998.00770.x","volume":"28","author":"NS Akopyants","year":"1998","unstructured":"Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA, et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol. 1998;28(1):37\u201353.","journal-title":"Mol Microbiol"},{"issue":"25","key":"1208_CR142","doi-asserted-by":"publisher","first-page":"14648","DOI":"10.1073\/pnas.93.25.14648","volume":"93","author":"S Censini","year":"1996","unstructured":"Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A. 1996;93(25):14648\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1208_CR143","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1084\/jem.191.4.587","volume":"191","author":"A Covacci","year":"2000","unstructured":"Covacci A, Rappuoli R. Tyrosine-phosphorylated bacterial protein trojan horses for the host cell. J Exp Med. 2000;191(4):587\u201392.","journal-title":"J Exp Med"},{"issue":"5555","key":"1208_CR144","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1126\/science.1067147","volume":"295","author":"H Higashi","year":"2002","unstructured":"Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295(5555):683\u20136.","journal-title":"Science"},{"issue":"5624","key":"1208_CR145","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1126\/science.1081919","volume":"300","author":"MR Amieva","year":"2003","unstructured":"Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science. 2003;300(5624):1430\u20134.","journal-title":"Science"},{"issue":"45","key":"1208_CR146","doi-asserted-by":"publisher","first-page":"16339","DOI":"10.1073\/pnas.0502598102","volume":"102","author":"F Bagnoli","year":"2005","unstructured":"Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci U S A. 2005;102(45):16339\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"1208_CR147","doi-asserted-by":"publisher","first-page":"10646","DOI":"10.1073\/pnas.0504927102","volume":"102","author":"AT Franco","year":"2005","unstructured":"Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, et al. Activation of \u03b2-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A. 2005;102(30):10646\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"1208_CR148","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1038\/sj.onc.1210251","volume":"26","author":"N Murata-Kamiya","year":"2007","unstructured":"Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the \u03b2-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26(32):4617\u201326.","journal-title":"Oncogene"},{"issue":"7142","key":"1208_CR149","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature05765","volume":"447","author":"I Saadat","year":"2007","unstructured":"Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, et al. Helicobacter pylori CagA targets PAR1\/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447(7142):330\u20133.","journal-title":"Nature"},{"issue":"9","key":"1208_CR150","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1084\/jem.20051027","volume":"202","author":"M Suzuki","year":"2005","unstructured":"Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C. Interaction of CagA with Crk plays an important role in Helicobacter pylori\u2013induced loss of gastric epithelial cell adhesion. J Exp Med. 2005;202(9):1235\u201347.","journal-title":"J Exp Med"},{"issue":"4","key":"1208_CR151","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","volume":"23","author":"LE Wroblewski","year":"2010","unstructured":"Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713\u201339.","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"1208_CR152","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1136\/gutjnl-2011-301625","volume":"62","author":"Y Hayashi","year":"2013","unstructured":"Hayashi Y, Tsujii M, Wang J, Kondo J, Akasaka T, Jin Y, et al. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut. 2013;62(11):1536\u201346.","journal-title":"Gut"},{"issue":"1","key":"1208_CR153","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.gastro.2012.10.002","volume":"144","author":"AS Cheng","year":"2013","unstructured":"Cheng AS, Li MS, Kang W, Cheng VY, Chou JL, Lau SS, et al. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology. 2013;144(1):122-33.e9.","journal-title":"Gastroenterology"},{"issue":"11","key":"1208_CR154","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ni1131","volume":"5","author":"J Viala","year":"2004","unstructured":"Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5(11):1166\u201374.","journal-title":"Nat Immunol"},{"issue":"6","key":"1208_CR155","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/toxins8060190","volume":"8","author":"C Utsch","year":"2016","unstructured":"Utsch C, Haas R. VacA\u2019s induction of VacA-containing vacuoles (VCVs) and their immunomodulatory activities on human T cells. Toxins. 2016;8(6):190.","journal-title":"Toxins"},{"issue":"38","key":"1208_CR156","doi-asserted-by":"publisher","first-page":"16032","DOI":"10.1073\/pnas.1105175108","volume":"108","author":"P Jain","year":"2011","unstructured":"Jain P, Luo Z-Q, Blanke SR. Helicobacter pylori vacuolating cytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. Proc Natl Acad Sci U S A. 2011;108(38):16032\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1208_CR157","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1086\/596660","volume":"199","author":"TA Nagy","year":"2009","unstructured":"Nagy TA, Frey MR, Yan F, Israel DA, Polk DB, Peek RM. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis. 2009;199(5):641\u201351.","journal-title":"J Infect Dis"},{"issue":"9","key":"1208_CR158","first-page":"1360","volume":"55","author":"A Dossumbekova","year":"2006","unstructured":"Dossumbekova A, Prinz C, Gerhard M, Brenner L, Backert S, Kusters J, et al. Helicobacter pylori outer membrane proteins and gastric inflammation. Gut. 2006;55(9):1360\u20131.","journal-title":"Gut"},{"key":"1208_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117754","volume":"254","author":"S Soleimanpour","year":"2020","unstructured":"Soleimanpour S, Hasanian SM, Avan A, Yaghoubi A, Khazaei M. Bacteriotherapy in gastrointestinal cancer. Life Sci. 2020;254:117754.","journal-title":"Life Sci"},{"issue":"1","key":"1208_CR160","volume":"1874","author":"A Yaghoubi","year":"2020","unstructured":"Yaghoubi A, Khazaei M, Jalili S, Hasanian SM, Avan A, Soleimanpour S, et al. Bacteria as a double-action sword in cancer. Biochimica et Biophysica Acta (BBA). 2020;1874(1):188388.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"1208_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.641322","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Zhou X, Liu X, Ling Z, Ji F. Role of the gastric microbiome in gastric cancer: from carcinogenesis to treatment. Front Microbiol. 2021;12:641322.","journal-title":"Front Microbiol"},{"issue":"8","key":"1208_CR162","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI32205","volume":"117","author":"CM Paulos","year":"2007","unstructured":"Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, et al. Microbial translocation augments the function of adoptively transferred self\/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest. 2007;117(8):2197\u2013204.","journal-title":"J Clin Invest"},{"issue":"1","key":"1208_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12365","volume":"7","author":"H Konishi","year":"2016","unstructured":"Konishi H, Fujiya M, Tanaka H, Ueno N, Moriichi K, Sasajima J, et al. Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nat Commun. 2016;7(1):12365.","journal-title":"Nat Commun"},{"key":"1208_CR164","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejca.2021.03.053","volume":"151","author":"G Zhu","year":"2021","unstructured":"Zhu G, Su H, Johnson CH, Khan SA, Kluger H, Lu L. Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma. Eur J Cancer. 2021;151:25\u201334.","journal-title":"Eur J Cancer"},{"issue":"6","key":"1208_CR165","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492\u2013506.","journal-title":"Cell Res"},{"issue":"12","key":"1208_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11123196","volume":"11","author":"K Zaher","year":"2023","unstructured":"Zaher K, Basingab F. Interaction between gut microbiota and dendritic cells in colorectal cancer. Biomedicines. 2023;11(12):3196.","journal-title":"Biomedicines"},{"key":"1208_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.04.032","author":"B Li","year":"2025","unstructured":"Li B, Elsten-Brown J, Li M, Zhu E, Li Z, Chen Y, et al. Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis. Cell. 2025. https:\/\/doi.org\/10.1016\/j.cell.2025.04.032.","journal-title":"Cell"},{"issue":"6","key":"1208_CR168","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1182\/blood-2003-08-2729","volume":"103","author":"NS Wilson","year":"2004","unstructured":"Wilson NS, El-Sukkari D, Villadangos JA. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood. 2004;103(6):2187\u201395.","journal-title":"Blood"},{"issue":"1","key":"1208_CR169","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tracli.2017.08.002","volume":"25","author":"N Deluce-Kakwata-Nkor","year":"2018","unstructured":"Deluce-Kakwata-Nkor N, Lamendour L, Chabot V, H\u00e9raud A, Ivanovic Z, Halary F, et al. Differentiation of human dendritic cell subsets for immune tolerance induction. Transfus Clin Biol. 2018;25(1):90\u20135.","journal-title":"Transfus Clin Biol"},{"key":"1208_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03176","volume":"9","author":"TA Patente","year":"2019","unstructured":"Patente TA, Pinho MP, Oliveira AA, Evangelista GC, Bergami-Santos PC, Barbuto JA. Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy. Front Immunol. 2019;9:3176.","journal-title":"Front Immunol"},{"issue":"6","key":"1208_CR171","doi-asserted-by":"publisher","first-page":"479","DOI":"10.21037\/hbsn.2018.10.02","volume":"7","author":"Y Shigematsu","year":"2018","unstructured":"Shigematsu Y, Inamura K. Gut microbiome: a key player in cancer immunotherapy. Hepatobiliary Surg Nutr. 2018;7(6):479.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"1208_CR172","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1172\/JCI124332","volume":"130","author":"M Uribe-Herranz","year":"2020","unstructured":"Uribe-Herranz M, Rafail S, Beghi S, Gil-de-G\u00f3mez L, Verginadis I, Bittinger K, et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. J Clin Invest. 2020;130(1):466\u201379.","journal-title":"J Clin Invest"},{"issue":"1","key":"1208_CR173","doi-asserted-by":"publisher","first-page":"16148","DOI":"10.1038\/srep16148","volume":"5","author":"C Nastasi","year":"2015","unstructured":"Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, et al. The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep. 2015;5(1):16148.","journal-title":"Sci Rep"},{"issue":"6264","key":"1208_CR174","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy. Science. 2015;350(6264):1084\u20139.","journal-title":"Science"},{"issue":"1","key":"1208_CR175","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/mbo3.221","volume":"4","author":"CK Mantri","year":"2015","unstructured":"Mantri CK, Chen CH, Dong X, Goodwin JS, Pratap S, Paromov V, et al. Fimbriae-mediated outer membrane vesicle production and invasion of P orphyromonas gingivalis. Microbiol Open. 2015;4(1):53\u201365.","journal-title":"Microbiol Open"},{"issue":"6371","key":"1208_CR176","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CP, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137.","journal-title":"Science"},{"issue":"11","key":"1208_CR177","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1128\/IAI.00567-10","volume":"78","author":"CW Kaplan","year":"2010","unstructured":"Kaplan CW, Ma X, Paranjpe A, Jewett A, Lux R, Kinder-Haake S, et al. Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes. Infect Immun. 2010;78(11):4773\u20138.","journal-title":"Infect Immun"},{"issue":"21","key":"1208_CR178","doi-asserted-by":"publisher","first-page":"11822","DOI":"10.3390\/ijms222111822","volume":"22","author":"J Jeong","year":"2021","unstructured":"Jeong J, Lee HK. The role of CD4+ T cells and microbiota in the pathogenesis of asthma. Int J Mol Sci. 2021;22(21):11822.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"1208_CR179","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303351120","volume":"120","author":"T Mayassi","year":"2023","unstructured":"Mayassi T, Xavier RJ. Untangling the CD4 T cell response to the microbiota. Proc Natl Acad Sci USA. 2023;120(16):e2303351120.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1208_CR180","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-immunol-101320-011829","volume":"40","author":"II Ivanov","year":"2022","unstructured":"Ivanov II, Tuganbaev T, Skelly AN, Honda K. T cell responses to the microbiota. Annu Rev Immunol. 2022;40(1):559\u201387.","journal-title":"Annu Rev Immunol"},{"key":"1208_CR181","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.intimp.2017.09.024","volume":"52","author":"Q-Y Ma","year":"2017","unstructured":"Ma Q-Y, Huang D-Y, Zhang H-J, Wang S, Chen X-F. Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5+ CD4+ T cells in non-small cell lung cancer. Int Immunopharmacol. 2017;52:305\u20139.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"1208_CR182","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.immuni.2023.11.003","volume":"56","author":"L Brockmann","year":"2023","unstructured":"Brockmann L, Tran A, Huang Y, Edwards M, Ronda C, Wang HH, et al. Intestinal microbiota-specific Th17 cells possess regulatory properties and suppress effector T cells via c-MAF and IL-10. Immunity. 2023;56(12):2719-35.e7.","journal-title":"Immunity"},{"issue":"10","key":"1208_CR183","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.immuni.2024.09.011","volume":"57","author":"R Kedmi","year":"2024","unstructured":"Kedmi R, Littman DR. Antigen-presenting cells as specialized drivers of intestinal T cell functions. Immunity. 2024;57(10):2269\u201379.","journal-title":"Immunity"},{"issue":"1","key":"1208_CR184","volume":"2015","author":"L Gu\u00e9ry","year":"2015","unstructured":"Gu\u00e9ry L, Hugues S. Th17 cell plasticity and functions in cancer immunity. BioMed Res Int. 2015;2015(1):314620.","journal-title":"BioMed Res Int"},{"issue":"6","key":"1208_CR185","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","volume":"114","author":"I Kryczek","year":"2009","unstructured":"Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood. 2009;114(6):1141\u20139.","journal-title":"Blood"},{"issue":"11","key":"1208_CR186","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.humimm.2012.07.333","volume":"73","author":"D Chen","year":"2012","unstructured":"Chen D, Jiang R, Mao C, Shi L, Wang S, Yu L, et al. Chemokine\/chemokine receptor interactions contribute to the accumulation of Th17 cells in patients with esophageal squamous cell carcinoma. Hum Immunol. 2012;73(11):1068\u201372.","journal-title":"Hum Immunol"},{"issue":"3","key":"1208_CR187","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.4049\/jimmunol.0902813","volume":"184","author":"X Su","year":"2010","unstructured":"Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, Peng G. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol. 2010;184(3):1630\u201341.","journal-title":"J Immunol"},{"issue":"2","key":"1208_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05560-2","volume":"14","author":"AH Mohseni","year":"2023","unstructured":"Mohseni AH, Taghinezhad-S S, Casolaro V, Lv Z, Li D. Potential links between the microbiota and T cell immunity determine the tumor cell fate. Cell Death Dis. 2023;14(2):154.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1208_CR189","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178(4):795-806. e12.","journal-title":"Cell"},{"issue":"2","key":"1208_CR190","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","volume":"51","author":"A Bachem","year":"2019","unstructured":"Bachem A, Makhlouf C, Binger KJ, de Souza DP, Tull D, Hochheiser K, et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T cells. Immunity. 2019;51(2):285-97.e5.","journal-title":"Immunity"},{"key":"1208_CR191","doi-asserted-by":"crossref","unstructured":"Amy IY, Zhao L, Eaton KA, Ho S, Chen J, Poe S, et al. Gut microbiota modulate CD8 T cell responses to influence colitis-associated tumorigenesis. Cell Rep. 2020;31(1).","DOI":"10.1016\/j.celrep.2020.03.035"},{"issue":"6371","key":"1208_CR192","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97\u2013103.","journal-title":"Science"},{"issue":"6371","key":"1208_CR193","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre M-L, et al. The commensal microbiome is associated with anti\u2013PD-1 efficacy in metastatic melanoma patients. Science. 2018;359(6371):104\u20138.","journal-title":"Science"},{"issue":"1","key":"1208_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01273-9","volume":"15","author":"Y Lu","year":"2022","unstructured":"Lu Y, Yuan X, Wang M, He Z, Li H, Wang J, et al. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies. J Hematol Oncol. 2022;15(1):47.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"1208_CR195","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","volume":"57","author":"J Cong","year":"2024","unstructured":"Cong J, Liu P, Han Z, Ying W, Li C, Yang Y, et al. Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions. Immunity. 2024;57(4):876-89.e11.","journal-title":"Immunity"},{"issue":"15","key":"1208_CR196","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153563","volume":"14","author":"A Aghamajidi","year":"2022","unstructured":"Aghamajidi A, Maleki Vareki S. The effect of the gut microbiota on systemic and anti-tumor immunity and response to systemic therapy against cancer. Cancers. 2022;14(15):3563.","journal-title":"Cancers"},{"key":"1208_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.765044","volume":"12","author":"Z Zhong","year":"2021","unstructured":"Zhong Z, Nan K, Weng M, Yue Y, Zhou W, Wang Z, et al. Pro-and anti-effects of immunoglobulin A-producing B cell in tumors and its triggers. Front Immunol. 2021;12:765044.","journal-title":"Front Immunol"},{"issue":"1","key":"1208_CR198","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1084\/jem.20150567","volume":"213","author":"D Ruane","year":"2016","unstructured":"Ruane D, Chorny A, Lee H, Faith J, Pandey G, Shan M, et al. Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses. J Exp Med. 2016;213(1):53\u201373.","journal-title":"J Exp Med"},{"issue":"4","key":"1208_CR199","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/intimm\/dxz078","volume":"32","author":"J Isobe","year":"2020","unstructured":"Isobe J, Maeda S, Obata Y, Iizuka K, Nakamura Y, Fujimura Y, et al. Commensal-bacteria-derived butyrate promotes the T-cell-independent IgA response in the colon. Int Immunol. 2020;32(4):243\u201358.","journal-title":"Int Immunol"},{"issue":"1","key":"1208_CR200","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-01741-x","volume":"4","author":"TT Sims","year":"2021","unstructured":"Sims TT, El Alam MB, Karpinets TV, Dorta-Estremera S, Hegde VL, Nookala S, et al. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol. 2021;4(1):237.","journal-title":"Commun Biol"},{"issue":"7","key":"1208_CR201","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.celrep.2019.10.018","volume":"29","author":"CJ Piper","year":"2019","unstructured":"Piper CJ, Rosser EC, Oleinika K, Nistala K, Krausgruber T, Rendeiro AF, et al. Aryl hydrocarbon receptor contributes to the transcriptional program of IL-10-producing regulatory B cells. Cell Rep. 2019;29(7):1878-92.e7.","journal-title":"Cell Rep"},{"issue":"5","key":"1208_CR202","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jaci.2010.09.026","volume":"126","author":"I Puga","year":"2010","unstructured":"Puga I, Cols M, Cerutti A. Innate signals in mucosal immunoglobulin class switching. J Allergy Clin Immunol. 2010;126(5):889\u201395.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1208_CR203","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cmet.2021.05.008","volume":"33","author":"EC Rosser","year":"2021","unstructured":"Rosser EC, Mauri C. The emerging field of regulatory B cell immunometabolism. Cell Metab. 2021;33(6):1088\u201397.","journal-title":"Cell Metab"},{"issue":"12","key":"1208_CR204","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","volume":"54","author":"AE Overacre-Delgoffe","year":"2021","unstructured":"Overacre-Delgoffe AE, Bumgarner HJ, Cillo AR, Burr AH, Tometich JT, Bhattacharjee A, et al. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer. Immunity. 2021;54(12):2812-24.e4.","journal-title":"Immunity"},{"issue":"3","key":"1208_CR205","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010681","volume":"13","author":"MK Wong","year":"2025","unstructured":"Wong MK, Boukhaled GM, Armstrong E, Liu R, Heirali AA, Yee NR, et al. Microbial ecosystem therapeutics 4 (MET4) elicits treatment-specific IgG responses associated with changes in gut microbiota in immune checkpoint inhibitor recipients with advanced solid tumors. J Immunother Cancer. 2025;13(3):e010681.","journal-title":"J Immunother Cancer"},{"issue":"20","key":"1208_CR206","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1182\/blood-2012-09-459289","volume":"121","author":"D Pinto","year":"2013","unstructured":"Pinto D, Montani E, Bolli M, Garavaglia G, Sallusto F, Lanzavecchia A, et al. A functional BCR in human IgA and IgM plasma cells. Blood. 2013;121(20):4110\u20134.","journal-title":"Blood"},{"issue":"5","key":"1208_CR207","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","volume":"20","author":"GV Sharonov","year":"2020","unstructured":"Sharonov GV, Serebrovskaya EO, Yuzhakova DV, Britanova OV, Chudakov DM. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat Rev Immunol. 2020;20(5):294\u2013307.","journal-title":"Nat Rev Immunol"},{"issue":"7550","key":"1208_CR208","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature14395","volume":"521","author":"S Shalapour","year":"2015","unstructured":"Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D, et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 2015;521(7550):94\u20138.","journal-title":"Nature"},{"issue":"7680","key":"1208_CR209","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature24302","volume":"551","author":"S Shalapour","year":"2017","unstructured":"Shalapour S, Lin X-J, Bastian IN, Brain J, Burt AD, Aksenov AA, et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature. 2017;551(7680):340\u20135.","journal-title":"Nature"},{"issue":"2","key":"1208_CR210","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","volume":"35","author":"A Schietinger","year":"2014","unstructured":"Schietinger A, Greenberg PD. Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol. 2014;35(2):51\u201360.","journal-title":"Trends Immunol"},{"issue":"4","key":"1208_CR211","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1208_CR212","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.gastro.2017.09.045","volume":"154","author":"R Liu","year":"2018","unstructured":"Liu R, Lu Z, Gu J, Liu J, Huang E, Liu X, et al. MicroRNAs 15A and 16\u20131 activate signaling pathways that mediate chemotaxis of immune regulatory B cells to colorectal tumors. Gastroenterology. 2018;154(3):637-51.e7.","journal-title":"Gastroenterology"},{"issue":"4","key":"1208_CR213","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/modpathol.2016.28","volume":"29","author":"FM Bosisio","year":"2016","unstructured":"Bosisio FM, Wilmott JS, Volders N, Mercier M, Wouters J, Stas M, et al. Plasma cells in primary melanoma. Prognostic significance and possible role of IgA. Mod Pathol. 2016;29(4):347\u201358.","journal-title":"Mod Pathol"},{"issue":"4","key":"1208_CR214","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1294296","volume":"6","author":"G Chiaruttini","year":"2017","unstructured":"Chiaruttini G, Mele S, Opzoomer J, Crescioli S, Ilieva KM, Lacy KE, et al. B cells and the humoral response in melanoma: the overlooked players of the tumor microenvironment. Oncoimmunology. 2017;6(4):e1294296.","journal-title":"Oncoimmunology"},{"key":"1208_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2016.e00143","author":"C Welinder","year":"2016","unstructured":"Welinder C, Jirstr\u00f6m K, Lehn S, Nodin B, Marko-Varga G, Blixt O, et al. Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer. Heliyon. 2016. https:\/\/doi.org\/10.1016\/j.heliyon.2016.e00143.","journal-title":"Heliyon"},{"issue":"2","key":"1208_CR216","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nm.2087","volume":"16","author":"TB Clarke","year":"2010","unstructured":"Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 2010;16(2):228\u201331.","journal-title":"Nat Med"},{"issue":"7570","key":"1208_CR217","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature15367","volume":"525","author":"D Zhang","year":"2015","unstructured":"Zhang D, Chen G, Manwani D, Mortha A, Xu C, Faith JJ, et al. Neutrophil ageing is regulated by the microbiome. Nature. 2015;525(7570):528\u201332.","journal-title":"Nature"},{"issue":"20","key":"1208_CR218","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1182\/blood-2018-11-844555","volume":"133","author":"D Zhang","year":"2019","unstructured":"Zhang D, Frenette PS. Cross talk between neutrophils and the microbiota. Blood. 2019;133(20):2168\u201377.","journal-title":"Blood"},{"issue":"4","key":"1208_CR219","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/imm.12159","volume":"140","author":"D Karmarkar","year":"2013","unstructured":"Karmarkar D, Rock KL. Microbiota signalling through MyD88 is necessary for a systemic neutrophilic inflammatory response. Immunology. 2013;140(4):483\u201392.","journal-title":"Immunology"},{"key":"1208_CR220","doi-asserted-by":"crossref","unstructured":"De Meo ML, Spicer JD, editors. The role of neutrophil extracellular traps in cancer progression and metastasis. Seminars in immunology. Elsevier; 2021.","DOI":"10.1016\/j.smim.2022.101595"},{"issue":"8","key":"1208_CR221","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1172\/JCI67484","volume":"123","author":"J Cools-Lartigue","year":"2013","unstructured":"Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S, Giannias B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest. 2013;123(8):3446\u201358.","journal-title":"J Clin Invest"},{"issue":"15","key":"1208_CR222","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.7150\/jca.44215","volume":"11","author":"L Yang","year":"2020","unstructured":"Yang L, Liu L, Zhang R, Hong J, Wang Y, Wang J, et al. IL-8 mediates a positive loop connecting increased neutrophil extracellular traps (NETs) and colorectal cancer liver metastasis. J Cancer. 2020;11(15):4384.","journal-title":"J Cancer"},{"key":"1208_CR223","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1081585","volume":"13","author":"W Zhao","year":"2022","unstructured":"Zhao W, Dai S, Yue L, Xu F, Gu J, Dai X, et al. Emerging mechanisms progress of colorectal cancer liver metastasis. Front Endocrinol. 2022;13:1081585.","journal-title":"Front Endocrinol"},{"key":"1208_CR224","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.micpath.2019.03.036","volume":"131","author":"HM Alyami","year":"2019","unstructured":"Alyami HM, Finoti LS, Teixeira HS, Aljefri A, Kinane DF, Benakanakere MR. Role of NOD1\/NOD2 receptors in Fusobacterium nucleatum mediated NETosis. Microb Pathog. 2019;131:53\u201364.","journal-title":"Microb Pathog"},{"issue":"1","key":"1208_CR225","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02817-8","volume":"42","author":"X Kong","year":"2023","unstructured":"Kong X, Zhang Y, Xiang L, You Y, Duan Y, Zhao Y, et al. Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression. J Exp Clin Cancer Res. 2023;42(1):236.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"1208_CR226","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.immuni.2022.05.014","volume":"55","author":"A Ignacio","year":"2022","unstructured":"Ignacio A, Shah K, Bernier-Latmani J, K\u00f6ller Y, Coakley G, Moyat M, et al. Small intestinal resident eosinophils maintain gut homeostasis following microbial colonization. Immunity. 2022;55(7):1250-67.e12.","journal-title":"Immunity"},{"key":"1208_CR227","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00155","volume":"11","author":"R Jim\u00e9nez-Saiz","year":"2020","unstructured":"Jim\u00e9nez-Saiz R, Anipindi VC, Galipeau H, Ellenbogen Y, Chaudhary R, Koenig JF, et al. Microbial regulation of enteric eosinophils and its impact on tissue remodeling and Th2 immunity. Front Immunol. 2020;11:155.","journal-title":"Front Immunol"},{"issue":"9","key":"1208_CR228","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094377","volume":"22","author":"EM Sturm","year":"2021","unstructured":"Sturm EM, Knuplez E, Marsche G. Role of short chain fatty acids and apolipoproteins in the regulation of eosinophilia-associated diseases. Int J Mol Sci. 2021;22(9):4377.","journal-title":"Int J Mol Sci"},{"key":"1208_CR229","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186892","volume":"14","author":"X-f Liu","year":"2023","unstructured":"Liu X-f, Shao J-h, Liao Y-T, Wang L-N, Jia Y, Dong P-j, et al. Regulation of short-chain fatty acids in the immune system. Front Immunol. 2023;14:1186892.","journal-title":"Front Immunol"},{"issue":"13","key":"1208_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137379","volume":"25","author":"Y Du","year":"2024","unstructured":"Du Y, He C, An Y, Huang Y, Zhang H, Fu W, et al. The role of short chain fatty acids in inflammation and body health. Int J Mol Sci. 2024;25(13):7379.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1208_CR231","doi-asserted-by":"publisher","first-page":"E762","DOI":"10.1073\/pnas.1518589113","volume":"113","author":"JE Oh","year":"2016","unstructured":"Oh JE, Kim B-C, Chang D-H, Kwon M, Lee SY, Kang D, et al. Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa. Proc Natl Acad Sci USA. 2016;113(6):E762\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"1208_CR232","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713504","volume":"24","author":"Y Wang","year":"2023","unstructured":"Wang Y, He C, Xin S, Liu X, Zhang S, Qiao B, et al. A deep view of the biological property of interleukin-33 and its dysfunction in the gut. Int J Mol Sci. 2023;24(17):13504.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1208_CR233","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/ni.3159","volume":"16","author":"R Carretero","year":"2015","unstructured":"Carretero R, Sektioglu IM, Garbi N, Salgado OC, Beckhove P, H\u00e4mmerling GJ. Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells. Nat Immunol. 2015;16(6):609\u201317.","journal-title":"Nat Immunol"},{"key":"1208_CR234","doi-asserted-by":"crossref","unstructured":"Marone G, Gambardella AR, Mattei F, Mancini J, Schiavoni G, Varricchi G. Basophils in tumor microenvironment and surroundings. Tumor Microenviron Hematopoietic Cells Part A. 2020:21\u201334.","DOI":"10.1007\/978-3-030-35723-8_2"},{"issue":"7","key":"1208_CR235","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1158\/0008-5472.CAN-15-1801-T","volume":"76","author":"L De Monte","year":"2016","unstructured":"De Monte L, W\u00f6rmann S, Brunetto E, Heltai S, Magliacane G, Reni M, et al. Basophil recruitment into tumor-draining lymph nodes correlates with Th2 inflammation and reduced survival in pancreatic cancer patients. Cancer Res. 2016;76(7):1792\u2013803.","journal-title":"Cancer Res"},{"key":"1208_CR236","doi-asserted-by":"publisher","first-page":"1056838","DOI":"10.3389\/fimmu.2022.1056838","volume":"13","author":"R Poto","year":"2022","unstructured":"Poto R, Gambardella AR, Marone G, Schroeder JT, Mattei F, Schiavoni G, et al. Basophils from allergy to cancer. Front Immunol. 2022;13:1056838.","journal-title":"Front Immunol"},{"issue":"1","key":"1208_CR237","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/cancers14010075","volume":"14","author":"S Hiltbrunner","year":"2021","unstructured":"Hiltbrunner S, Spohn M-L, Wechsler R, Akhoundova D, Bankel L, Kasser S, et al. Comprehensive statistical exploration of prognostic (Bio-) markers for responses to immune checkpoint inhibitor in patients with non-small cell lung cancer. Cancers. 2021;14(1):75.","journal-title":"Cancers"},{"issue":"3","key":"1208_CR238","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/cells11030438","volume":"11","author":"J Chauhan","year":"2022","unstructured":"Chauhan J, Stavraka C, Grandits M, Palhares LC, Josephs DH, Lacy KE, et al. Clinical and translational significance of basophils in patients with cancer. Cells. 2022;11(3):438.","journal-title":"Cells"},{"issue":"5","key":"1208_CR239","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.chom.2013.10.004","volume":"14","author":"J Cahenzli","year":"2013","unstructured":"Cahenzli J, K\u00f6ller Y, Wyss M, Geuking MB, McCoy KD. Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe. 2013;14(5):559\u201370.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"1208_CR240","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jaci.2017.02.011","volume":"139","author":"T Gensollen","year":"2017","unstructured":"Gensollen T, Blumberg RS. Correlation between early-life regulation of the immune system by microbiota and allergy development. J Allergy Clin Immunol. 2017;139(4):1084\u201391.","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"1208_CR241","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171437","volume":"13","author":"NK Shakhpazyan","year":"2024","unstructured":"Shakhpazyan NK, Mikhaleva LM, Bedzhanyan AL, Gioeva ZV, Mikhalev AI, Midiber KY, et al. Exploring the role of the gut microbiota in modulating colorectal cancer immunity. Cells. 2024;13(17):1437.","journal-title":"Cells"},{"issue":"3","key":"1208_CR242","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41591-024-02803-3","volume":"30","author":"JR Bj\u00f6rk","year":"2024","unstructured":"Bj\u00f6rk JR, Bolte LA, Maltez Thomas A, Lee KA, Rossi N, Wind TT, et al. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma. Nat Med. 2024;30(3):785\u201396.","journal-title":"Nat Med"},{"issue":"3","key":"1208_CR243","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-022-01695-5","volume":"28","author":"KA Lee","year":"2022","unstructured":"Lee KA, Thomas AM, Bolte LA, Bj\u00f6rk JR, de Ruijter LK, Armanini F, et al. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nat Med. 2022;28(3):535\u201344.","journal-title":"Nat Med"},{"issue":"13","key":"1208_CR244","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1016\/j.cell.2024.05.029","volume":"187","author":"L Derosa","year":"2024","unstructured":"Derosa L, Iebba V, Silva CAC, Piccinno G, Wu G, Lordello L, et al. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome. Cell. 2024;187(13):3373-89.e16.","journal-title":"Cell"},{"issue":"4","key":"1208_CR245","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.eururo.2020.07.011","volume":"78","author":"NJ Salgia","year":"2020","unstructured":"Salgia NJ, Bergerot PG, Maia MC, Dizman N, Hsu J, Gillece JD, et al. Stool microbiome profiling of patients with metastatic renal cell carcinoma receiving anti\u2013PD-1 immune checkpoint inhibitors. Eur Urol. 2020;78(4):498\u2013502.","journal-title":"Eur Urol"},{"issue":"6","key":"1208_CR246","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/hep4.1905","volume":"6","author":"FR Ponziani","year":"2022","unstructured":"Ponziani FR, De Luca A, Picca A, Marzetti E, Petito V, Del Chierico F, et al. Gut dysbiosis and fecal calprotectin predict response to immune checkpoint inhibitors in patients with hepatocellular carcinoma. Hepatol Commun. 2022;6(6):1492\u2013501.","journal-title":"Hepatol Commun"},{"issue":"4","key":"1208_CR247","first-page":"1040","volume":"18","author":"H Yin","year":"2021","unstructured":"Yin H, Yang L, Peng G, Yang K, Mi Y, Hu X, et al. The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms. Cancer Biol Med. 2021;18(4):1040\u201352.","journal-title":"Cancer Biol Med"},{"issue":"6264","key":"1208_CR248","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350(6264):1079\u201384.","journal-title":"Science"},{"issue":"1","key":"1208_CR249","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00442-x","volume":"12","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu J, Xia Q. Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target. Exp Hematol Oncol. 2023;12(1):84.","journal-title":"Exp Hematol Oncol"},{"issue":"6529","key":"1208_CR250","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin J-M, Morrison RM, et al. Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients. Science. 2021;371(6529):595\u2013602.","journal-title":"Science"},{"issue":"6529","key":"1208_CR251","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371(6529):602\u20139.","journal-title":"Science"},{"key":"1208_CR252","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-118628","volume":"132","author":"M Smith","year":"2018","unstructured":"Smith M, Littmann ER, Slingerland JB, Clurman A, Slingerland AE, Taur Y, et al. Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity. Blood. 2018;132:3492.","journal-title":"Blood"},{"key":"1208_CR253","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-153945","volume":"138","author":"M Smith","year":"2021","unstructured":"Smith M, Dai A, Ghilardi G, Amelsberg K, Devlin SM, Pajarillo R, et al. The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies. Blood. 2021;138:253.","journal-title":"Blood"},{"issue":"9","key":"1208_CR254","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000950","volume":"7","author":"G Gabrielli","year":"2023","unstructured":"Gabrielli G, Shouval R, Ghilardi G, van den Brink M, Ruella M. Harnessing the gut microbiota to potentiate the efficacy of CAR T cell therapy. Hemasphere. 2023;7(9):e950.","journal-title":"Hemasphere"},{"issue":"4","key":"1208_CR255","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41591-022-01702-9","volume":"28","author":"M Smith","year":"2022","unstructured":"Smith M, Dai A, Ghilardi G, Amelsberg KV, Devlin SM, Pajarillo R, et al. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med. 2022;28(4):713\u201323.","journal-title":"Nat Med"},{"issue":"6469","key":"1208_CR256","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.aax3760","volume":"366","author":"CK Stein-Thoeringer","year":"2019","unstructured":"Stein-Thoeringer CK, Nichols KB, Lazrak A, Docampo MD, Slingerland AE, Slingerland J, et al. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science. 2019;366(6469):1143\u20139.","journal-title":"Science"},{"issue":"4","key":"1208_CR257","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","volume":"29","author":"CK Stein-Thoeringer","year":"2023","unstructured":"Stein-Thoeringer CK, Saini NY, Zamir E, Blumenberg V, Schubert M-L, Mor U, et al. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat Med. 2023;29(4):906\u201316.","journal-title":"Nat Med"},{"issue":"3","key":"1208_CR258","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ymthe.2023.01.012","volume":"31","author":"M Uribe-Herranz","year":"2023","unstructured":"Uribe-Herranz M, Beghi S, Ruella M, Parvathaneni K, Salaris S, Kostopoulos N, et al. Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy. Mol Ther. 2023;31(3):686\u2013700.","journal-title":"Mol Ther"},{"issue":"1","key":"1208_CR259","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32960-3","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Li J, Ni F, Yang Z, Gui X, Bao Z, et al. CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies. Nat Commun. 2022;13(1):5313.","journal-title":"Nat Commun"},{"key":"1208_CR260","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1362133","volume":"15","author":"P-F Zhang","year":"2024","unstructured":"Zhang P-F, Xie D. Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope? Front Immunol. 2024;15:1362133.","journal-title":"Front Immunol"},{"issue":"1","key":"1208_CR261","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12929-025-01125-x","volume":"32","author":"Y Fang","year":"2025","unstructured":"Fang Y, Chen Y, Niu S, Lyu Z, Tian Y, Shen X, et al. Biological functions and therapeutic applications of human mucosal-associated invariant T cells. J Biomed Sci. 2025;32(1):32.","journal-title":"J Biomed Sci"},{"key":"1208_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2025.03.011","author":"Y-R Li","year":"2025","unstructured":"Li Y-R, Shen X, Zhu Y, Lyu Z, Yang L. The microbiota shapes the life trajectory of mucosal-associated invariant T cells. Trends Microbiol. 2025. https:\/\/doi.org\/10.1016\/j.tim.2025.03.011.","journal-title":"Trends Microbiol"},{"issue":"6","key":"1208_CR263","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5603\/AHP.a2022.0053","volume":"53","author":"K Zielonka","year":"2022","unstructured":"Zielonka K, Jasi\u0144ski M, Jamroziak K. Influence of gut microbiota on efficacy and adverse effects of treatment of lymphoproliferative disorders. Acta Haematol Pol. 2022;53(6):363\u201375.","journal-title":"Acta Haematol Pol"},{"issue":"1","key":"1208_CR264","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.156","volume":"3","author":"J Xie","year":"2024","unstructured":"Xie J, Liu M, Deng X, Tang Y, Zheng S, Ou X, et al. Gut microbiota reshapes cancer immunotherapy efficacy: mechanisms and therapeutic strategies. Imeta. 2024;3(1):e156.","journal-title":"Imeta"},{"issue":"1","key":"1208_CR265","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-01060-x","volume":"31","author":"M Azhar Ud Din","year":"2025","unstructured":"Azhar Ud Din M, Lin Y, Lyu C, Yi C, Fang A, Mao F. Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions. Mol Med. 2025;31(1):2.","journal-title":"Mol Med"},{"issue":"4","key":"1208_CR266","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","volume":"33","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell. 2018;33(4):570\u201380.","journal-title":"Cancer Cell"},{"issue":"8","key":"1208_CR267","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.bbmt.2015.04.016","volume":"21","author":"RR Jenq","year":"2015","unstructured":"Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, et al. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(8):1373\u201383.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"1208_CR268","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13361","volume":"32","author":"D Hidaka","year":"2018","unstructured":"Hidaka D, Hayase E, Shiratori S, Hasegawa Y, Ishio T, Tateno T, et al. The association between the incidence of intestinal graft\u2010vs\u2010host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2018;32(9):e13361.","journal-title":"Clin Transplant"},{"issue":"5","key":"1208_CR269","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bbmt.2017.02.006","volume":"23","author":"D Weber","year":"2017","unstructured":"Weber D, Jenq RR, Peled JU, Taur Y, Hiergeist A, Koestler J, et al. Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23(5):845\u201352.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1208_CR270","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932228","volume":"13","author":"T Sen","year":"2022","unstructured":"Sen T, Thummer RP. The impact of human microbiotas in hematopoietic stem cell and organ transplantation. Front Immunol. 2022;13:932228.","journal-title":"Front Immunol"},{"issue":"1","key":"1208_CR271","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121\u201341.","journal-title":"Cell"},{"issue":"1","key":"1208_CR272","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2301801","volume":"25","author":"L Yang","year":"2024","unstructured":"Yang L, Wang Q, He L, Sun X. The critical role of tumor microbiome in cancer immunotherapy. Cancer Biol Ther. 2024;25(1):2301801.","journal-title":"Cancer Biol Ther"},{"issue":"7448","key":"1208_CR273","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature12079","volume":"497","author":"A Cebula","year":"2013","unstructured":"Cebula A, Seweryn M, Rempala GA, Pabla SS, McIndoe RA, Denning TL, et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature. 2013;497(7448):258\u201362.","journal-title":"Nature"},{"issue":"1","key":"1208_CR274","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32860-x","volume":"8","author":"M Luu","year":"2018","unstructured":"Luu M, Weigand K, Wedi F, Breidenbend C, Leister H, Pautz S, et al. Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate. Sci Rep. 2018;8(1):14430.","journal-title":"Sci Rep"},{"issue":"6","key":"1208_CR275","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.immuni.2016.03.016","volume":"44","author":"ML Balmer","year":"2016","unstructured":"Balmer ML, Ma EH, Bantug GR, Gr\u00e4hlert J, Pfister S, Glatter T, et al. Memory CD8+ T cells require increased concentrations of acetate induced by stress for optimal function. Immunity. 2016;44(6):1312\u201324.","journal-title":"Immunity"},{"issue":"4","key":"1208_CR276","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","volume":"45","author":"R Daill\u00e8re","year":"2016","unstructured":"Daill\u00e8re R, V\u00e9tizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, et al. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity. 2016;45(4):931\u201343.","journal-title":"Immunity"},{"key":"1208_CR277","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107668","author":"L Tripodi","year":"2023","unstructured":"Tripodi L, Feola S, Granata I, Whalley T, Passariello M, Capasso C, et al. Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma. IScience. 2023. https:\/\/doi.org\/10.1016\/j.isci.2023.107668.","journal-title":"IScience"},{"issue":"4","key":"1208_CR278","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1007\/s10620-024-08346-4","volume":"69","author":"X Chen","year":"2024","unstructured":"Chen X, Wang G, Qin L, Hu B, Li J. Intestinal microbiota modulates the antitumor effect of oncolytic virus vaccines in colorectal cancer. Dig Dis Sci. 2024;69(4):1228\u201341.","journal-title":"Dig Dis Sci"},{"key":"1208_CR279","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.104967","author":"Y Yang","year":"2024","unstructured":"Yang Y, An Y, Dong Y, Chu Q, Wei J, Wang B, et al. Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy. EBioMedicine. 2024. https:\/\/doi.org\/10.1016\/j.ebiom.2024.104967.","journal-title":"EBioMedicine"},{"issue":"10336","key":"1208_CR280","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/S0140-6736(22)00562-1","volume":"399","author":"JJ Luke","year":"2022","unstructured":"Luke JJ, Rutkowski P, Queirolo P, Del Vecchio M, Mackiewicz J, Chiarion-Sileni V, et al. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial. Lancet. 2022;399(10336):1718\u201329.","journal-title":"Lancet"},{"key":"1208_CR281","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231204854","volume":"15","author":"J Huang","year":"2023","unstructured":"Huang J, Gong C, Zhou A. Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors. Ther Adv Med Oncol. 2023;15:17588359231204854.","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"1208_CR282","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"key":"1208_CR283","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.2657","volume-title":"Fecal microbiota transplantation for refractory immune-checkpoint-inhibitor colitis","author":"A Elkrief","year":"2023","unstructured":"Elkrief A, Nicholas W, Smith N, Dai A, Slingerland JB, Aleynick N, et al. Fecal microbiota transplantation for refractory immune-checkpoint-inhibitor colitis. American Society of Clinical Oncology; 2023."},{"issue":"5","key":"1208_CR284","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cgh.2018.01.018","volume":"17","author":"C De Simone","year":"2019","unstructured":"De Simone C. The unregulated probiotic market. Clin Gastroenterol Hepatol. 2019;17(5):809\u201317.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6575","key":"1208_CR285","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","volume":"374","author":"CN Spencer","year":"2021","unstructured":"Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374(6575):1632\u201340.","journal-title":"Science"},{"issue":"4","key":"1208_CR286","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","volume":"28","author":"N Dizman","year":"2022","unstructured":"Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat Med. 2022;28(4):704\u201312.","journal-title":"Nat Med"},{"key":"1208_CR287","unstructured":"De Ana CL, Prince A, Darrah E, Buresh S, Menon R, Norman J, et al. 607 CONSORTIUM-IO: a phase 1 study evaluating a combination of an 11-strain bacterial consortium (VE800) and nivolumab in treatment of select refractory or metastatic cancers. BMJ Special J; 2024."},{"key":"1208_CR288","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108706","author":"C Han","year":"2021","unstructured":"Han C, Song J, Hu J, Fu H, Feng Y, Mu R, et al. Smectite promotes probiotic biofilm formation in the gut for cancer immunotherapy. Cell Rep. 2021. https:\/\/doi.org\/10.1016\/j.celrep.2021.108706.","journal-title":"Cell Rep"},{"issue":"6","key":"1208_CR289","first-page":"1908","volume":"27","author":"F Guarner","year":"2012","unstructured":"Guarner F, Hern\u00e1ndez M, Garc\u00eda-Peris P, Velasco C, Lozano M, Moreno Y, et al. Effect of a mixture of inulin and fructo-oligosaccharide on lactobacillus and bifidobacterium intestinal microbiota of patients receiving radiotherapy; a randomised, double-blind, placebo-controlled trial. Nutr Hosp. 2012;27(6):1908\u201315.","journal-title":"Nutr Hosp"},{"issue":"11","key":"1208_CR290","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41551-021-00749-2","volume":"5","author":"K Han","year":"2021","unstructured":"Han K, Nam J, Xu J, Sun X, Huang X, Animasahun O, et al. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel. Nat Biomed Eng. 2021;5(11):1377\u201388.","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"1208_CR291","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-024-13234-1","volume":"24","author":"RM Farias","year":"2024","unstructured":"Farias RM, Jiang Y, Levy EJ, Hwang C, Wang J, Burton EM, et al. Diet and Immune Effects Trial (DIET)-a randomized, double-blinded dietary intervention study in patients with melanoma receiving immunotherapy. BMC Cancer. 2024;24(1):1\u201310.","journal-title":"BMC Cancer"},{"issue":"11","key":"1208_CR292","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1038\/s41591-022-01965-2","volume":"28","author":"RC Simpson","year":"2022","unstructured":"Simpson RC, Shanahan ER, Batten M, Reijers IL, Read M, Silva IP, et al. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome. Nat Med. 2022;28(11):2344\u201352.","journal-title":"Nat Med"},{"issue":"4","key":"1208_CR293","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1017\/S0007114508019880","volume":"101","author":"C Ramirez-Farias","year":"2008","unstructured":"Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr. 2008;101(4):541\u201350.","journal-title":"Br J Nutr"},{"key":"1208_CR294","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.968729","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Huang G, Wong W-C, Hu D-h, Zhu J-w, Li R, et al. The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors. Front Immunol. 2022;13:968729.","journal-title":"Front Immunol"},{"key":"1208_CR295","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-018-0592-6","volume":"11","author":"M Yi","year":"2018","unstructured":"Yi M, Yu S, Qin S, Liu Q, Xu H, Zhao W, et al. Gut microbiome modulates efficacy of immune checkpoint inhibitors. J Hematol Oncol. 2018;11:1\u201310.","journal-title":"J Hematol Oncol"},{"key":"1208_CR296","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1630310","volume":"16","author":"M Dai","year":"2025","unstructured":"Dai M, Bu S, Miao Z. Succinate metabolism: underlying biological mechanisms and emerging therapeutic targets in inflammatory bowel disease. Front Immunol. 2025;16:1630310.","journal-title":"Front Immunol"},{"issue":"1","key":"1208_CR297","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41368-025-00376-6","volume":"17","author":"F Xu","year":"2025","unstructured":"Xu F, Guo Y, Thomas SC, Saxena A, Hwang S, Vardhan M, et al. Succinate modulates oral dysbiosis and inflammation through a succinate receptor 1 dependent mechanism in aged mice. Int J Oral Sci. 2025;17(1):47.","journal-title":"Int J Oral Sci"},{"issue":"4","key":"1208_CR298","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s10753-023-01819-0","volume":"46","author":"Z Li","year":"2023","unstructured":"Li Z, Zheng W, Kong W, Zeng T. Itaconate: a potent macrophage immunomodulator. Inflammation. 2023;46(4):1177\u201391.","journal-title":"Inflammation"},{"issue":"7","key":"1208_CR299","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.celrep.2019.04.022","volume":"27","author":"J Qiu","year":"2019","unstructured":"Qiu J, Villa M, Sanin DE, Buck MD, O\u2019Sullivan D, Ching R, et al. Acetate promotes T cell effector function during glucose restriction. Cell Rep. 2019;27(7):2063-74.e5.","journal-title":"Cell Rep"},{"issue":"10","key":"1208_CR300","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s43018-023-00636-6","volume":"4","author":"KD Miller","year":"2023","unstructured":"Miller KD, O\u2019Connor S, Pniewski KA, Kannan T, Acosta R, Mirji G, et al. Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer. Nat cancer. 2023;4(10):1491\u2013507.","journal-title":"Nat cancer"},{"issue":"9","key":"1208_CR301","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231820","volume":"221","author":"I Kaymak","year":"2024","unstructured":"Kaymak I, Watson MJ, Oswald BM, Ma S, Johnson BK, DeCamp LM, et al. ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses. J Exp Med. 2024;221(9):e20231820.","journal-title":"J Exp Med"},{"issue":"1","key":"1208_CR302","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, et al. Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12(1):4077.","journal-title":"Nat Commun"},{"issue":"7","key":"1208_CR303","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004147","volume":"10","author":"P Rangan","year":"2022","unstructured":"Rangan P, Mondino A. Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy. J Immunother Cancer. 2022;10(7):e004147.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"1208_CR304","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","volume":"21","author":"S Ma","year":"2024","unstructured":"Ma S, Ming Y, Wu J, Cui G. Cellular metabolism regulates the differentiation and function of T-cell subsets. Cell Mol Immunol. 2024;21(5):419\u201335.","journal-title":"Cell Mol Immunol"},{"key":"1208_CR305","doi-asserted-by":"publisher","first-page":"1404441","DOI":"10.3389\/fimmu.2024.1404441","volume":"15","author":"H Huang","year":"2024","unstructured":"Huang H, Li G, He Y, Chen J, Yan J, Zhang Q, et al. Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention. Front Immunol. 2024;15:1404441.","journal-title":"Front Immunol"},{"issue":"24","key":"1208_CR306","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.3390\/cancers14246064","volume":"14","author":"R Najm","year":"2022","unstructured":"Najm R, Hachim MY, Kandasamy RK. Divulging a pleiotropic role of succinate receptor SUCNR1 in renal cell carcinoma microenvironment. Cancers. 2022;14(24):6064.","journal-title":"Cancers"},{"key":"1208_CR307","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2021.11.024","volume":"526","author":"P Rabe","year":"2022","unstructured":"Rabe P, Liebing A-D, Krumbholz P, Kraft R, St\u00e4ubert C. Succinate receptor 1 inhibits mitochondrial respiration in cancer cells addicted to glutamine. Cancer Lett. 2022;526:91\u2013102.","journal-title":"Cancer Lett"},{"issue":"5","key":"1208_CR308","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.chembiol.2024.02.001","volume":"31","author":"NM Chapman","year":"2024","unstructured":"Chapman NM, Chi H. Metabolic rewiring and communication in cancer immunity. Cell Chem Biol. 2024;31(5):862\u201383.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"1208_CR309","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-023-00503-3","volume":"28","author":"W Yang","year":"2023","unstructured":"Yang W, Wang Y, Tao K, Li R. Metabolite itaconate in host immunoregulation and defense. Cell Mol Biol Lett. 2023;28(1):100.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"1208_CR310","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2024.100224","volume":"4","author":"C Chen","year":"2025","unstructured":"Chen C, Li X. The cell autonomous and non-autonomous roles of itaconate in immune response. Cell Insight. 2025;4(1):100224.","journal-title":"Cell Insight"},{"issue":"7","key":"1208_CR311","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47070534","volume":"47","author":"K Ma","year":"2025","unstructured":"Ma K, Zhou P, Zhang W, Zeng L, Tao K, Zhang P. Itaconic acid: a regulator of immune responses and inflammatory metabolism. Curr Issues Mol Biol. 2025;47(7):534.","journal-title":"Curr Issues Mol Biol"},{"issue":"7","key":"1208_CR312","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41568-019-0155-3","volume":"19","author":"E Elinav","year":"2019","unstructured":"Elinav E, Garrett WS, Trinchieri G, Wargo J. The cancer microbiome. Nat Rev Cancer. 2019;19(7):371\u20136.","journal-title":"Nat Rev Cancer"},{"issue":"7741","key":"1208_CR313","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","volume":"565","author":"T Tanoue","year":"2019","unstructured":"Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y, et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019;565(7741):600\u20135.","journal-title":"Nature"},{"issue":"7","key":"1208_CR314","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","volume":"25","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury S, Castro S, Coker C, Hinchliffe TE, Arpaia N, Danino T. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med. 2019;25(7):1057\u201363.","journal-title":"Nat Med"},{"issue":"6285","key":"1208_CR315","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1126\/science.aad3369","volume":"352","author":"A Zhernakova","year":"2016","unstructured":"Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016;352(6285):565\u20139.","journal-title":"Science"},{"issue":"5","key":"1208_CR316","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O\u2019Toole","year":"2017","unstructured":"O\u2019Toole PW, Marchesi JR, Hill C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol. 2017;2(5):1\u20136.","journal-title":"Nat Microbiol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-025-01208-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-025-01208-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-025-01208-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:02:33Z","timestamp":1767571353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12929-025-01208-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":316,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1186\/s12929-025-01208-9","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}